12 most commonly reported adverse events by treatment group
| Preferred term | Mannitol (n=233) n (%) | Control (n=228) n (%) |
|---|---|---|
| Condition aggravated | 149 (63.9) | 159 (69.7) |
| Nasopharyngitis | 36 (15.5) | 30 (13.2) |
| Bacteria sputum identified | 30 (12.9) | 30 (13.2) |
| Cough | 30 (12.9) | 22 (9.6) |
| Headache | 27 (11.6) | 32 (14.0) |
| Haemoptysis | 24 (10.3) | 23 (10.1) |
| Dyspnoea | 20 (8.6) | 16 (7.0) |
| Back pain | 19 (8.2) | 13 (5.7) |
| Sinusitis | 17 (7.3) | 14 (6.1) |
| Lower respiratory tract infection | 28 (12.1) | 30 (13.2) |
| Diarrhoea | 15 (6.4) | 21 (9.2) |
| Nausea | 14 (6.0) | 18 (7.9) |